Earnings Call · Q4 FY2025·2026-02-26

Q4 25EPS -7.14%·Rev n/aQ3 25EPS -6.67%·Rev n/aQ2 25EPS -10.71%·Rev n/aQ1 25EPS -11.54%·Rev n/a⚠ consensus missing

Wave Life Sciences, Inc. WVE

Kate Rausch — Vice President of Corporate Affairs and Investor Relations

Paul Bolno — President and CEO

Christopher Wright — Chief Medical Officer

Kyle Moran — Chief Financial Officer

+5.6%1d on move date+6.2% vs SPY3d−4.7%5d−5.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more WVE calls or request research access.

More WVE calls Browse calls Request research access